Concepedia

Access with Evidence Development Schemes

Christopher McCabe, Tania Stafinski, Richard Edlin, Devidas Menon

PharmacoEconomics · 2010 · 87 citations · 7 references

DOI

Concepts

References

7

Rating neurologic impairment in multiple sclerosis

John F. Kurtzke · Neurology · 1983 · 14.9K citations

, , +14

Accountability for reasonableness: an update

Norman Daniels, James E. Sabin · BMJ · 2008 · 234 citations

, , +15

Exploring Uncertainty in Cost-Effectiveness Analysis

Karl Claxton · PharmacoEconomics · 2008 · 211 citations

, , +10

Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosisCommentary: Evaluating disease modifying treatments in multiple sclerosis

BMJ · 2003 · 144 citations · Full text

, , +17

The Multiple Sclerosis Risk Sharing Scheme Monitoring Study – early results and lessons for the future

Mark Pickin, Cindy Cooper, Tim Chater et al. · BMC Neurology · 2009 · 96 citations · Full text

, , +17